161 related articles for article (PubMed ID: 7503695)
21. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
[TBL] [Abstract][Full Text] [Related]
22. Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5.
Zárate S; Cuadras MA; Espinosa R; Romero P; Juárez KO; Camacho-Nuez M; Arias CF; López S
J Virol; 2003 Jul; 77(13):7254-60. PubMed ID: 12805424
[TBL] [Abstract][Full Text] [Related]
23. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
24. The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.
Mackow ER; Shaw RD; Matsui SM; Vo PT; Dang MN; Greenberg HB
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):645-9. PubMed ID: 2829198
[TBL] [Abstract][Full Text] [Related]
25. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*.
Yoo D; Lee J; Harland R; Gibbons E; Elazhary Y; Babiuk LA
Adv Exp Med Biol; 1997; 412():405-11. PubMed ID: 9192047
[TBL] [Abstract][Full Text] [Related]
26. Rotavirus VP4 Epitope of a Broadly Neutralizing Human Antibody Defined by Its Structure Bound with an Attenuated-Strain Virion.
Jenni S; Li Z; Wang Y; Bessey T; Salgado EN; Schmidt AG; Greenberg HB; Jiang B; Harrison SC
J Virol; 2022 Aug; 96(16):e0062722. PubMed ID: 35924923
[TBL] [Abstract][Full Text] [Related]
27. Recombinant baculovirus-expressed rotavirus protein (VP4) in an ELISPOT assay of antibody secretion.
Shaw RD; Groene WS; Mackow ER; Merchant AA; Cheng EH
Viral Immunol; 1992; 5(1):51-9. PubMed ID: 1319171
[TBL] [Abstract][Full Text] [Related]
28. VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies.
Nishikawa K; Fukuhara N; Liprandi F; Green K; Kapikian AZ; Chanock RM; Gorziglia M
Virology; 1989 Dec; 173(2):631-7. PubMed ID: 2480689
[TBL] [Abstract][Full Text] [Related]
29. Human rotavirus K8 strain represents a new VP4 serotype.
Li B; Larralde G; Gorziglia M
J Virol; 1993 Jan; 67(1):617-20. PubMed ID: 8380098
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a synthetic peptide mimicking trypsin-cleavage site of rotavirus VP4.
Ijaz MK; Alkarmi TO; Sabara MI; Frenchick PJ; el Mekki AA; Naiem M; Nur-e-Kamal MS; Frossard PM; Dar FK; Babiuk LA
Comp Immunol Microbiol Infect Dis; 1995 Jun; 18(3):145-60. PubMed ID: 7554816
[TBL] [Abstract][Full Text] [Related]
31. Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry.
Tihova M; Dryden KA; Bellamy AR; Greenberg HB; Yeager M
J Mol Biol; 2001 Dec; 314(5):985-92. PubMed ID: 11743716
[TBL] [Abstract][Full Text] [Related]
32. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
[TBL] [Abstract][Full Text] [Related]
33. [VP4 protein of simian rotavirus strain SA11 expressed by a baculovirus recombinant].
Sun M; Giambiagi S; Burrone O
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):48-53. PubMed ID: 10453552
[TBL] [Abstract][Full Text] [Related]
34. The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.
Lizano M; López S; Arias CF
J Virol; 1991 Mar; 65(3):1383-91. PubMed ID: 1847459
[TBL] [Abstract][Full Text] [Related]
35. Trypsin is associated with the rotavirus capsid and is activated by solubilization of outer capsid proteins.
Benureau Y; Huet JC; Charpilienne A; Poncet D; Cohen J
J Gen Virol; 2005 Nov; 86(Pt 11):3143-3151. PubMed ID: 16227238
[TBL] [Abstract][Full Text] [Related]
36. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
37. Rotavirus capsid protein VP5* permeabilizes membranes.
Denisova E; Dowling W; LaMonica R; Shaw R; Scarlata S; Ruggeri F; Mackow ER
J Virol; 1999 Apr; 73(4):3147-53. PubMed ID: 10074166
[TBL] [Abstract][Full Text] [Related]
38. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice.
Dharakul T; Labbe M; Cohen J; Bellamy AR; Street JE; Mackow ER; Fiore L; Rott L; Greenberg HB
J Virol; 1991 Nov; 65(11):5928-32. PubMed ID: 1656079
[TBL] [Abstract][Full Text] [Related]
39. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.
Kirkwood CD; Bishop RF; Coulson BS
Arch Virol; 1996; 141(3-4):587-600. PubMed ID: 8645097
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
